Advertisement
NCI vs XELB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCI is a Hold and XELB is a StrongBuy.
NCI in -11.40% downward trend, falling for three consecutive days on October 16, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NCI declined for three days, in 136 of 147 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NCI as a result. In 42 of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
NCI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NCI crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for NCI entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for NCI just turned positive on October 19, 2026. Looking at past instances where NCI's MACD turned positive, the stock continued to rise in 16 of 17 cases over the following month. The odds of a continued upward trend are 90%.
Following a +19.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where NCI advanced for three days, in 103 of 112 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
NCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.851) is normal, around the industry mean (2.700). P/E Ratio (1.126) is within average values for comparable stocks, (14.111). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.686). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (0.387) is also within normal values, averaging (0.827).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. NCI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
XELB's Stochastic Oscillator stoops into oversold zone
The Stochastic Oscillator for XELB moved into oversold territory on October 22, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for XELB's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a +26.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where XELB advanced for three days, in 175 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
XELB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XELB as a result. In 84 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for XELB turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 51 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XELB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for XELB entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XELB's P/B Ratio (0.178) is slightly lower than the industry average of (2.700). P/E Ratio (-0.123) is within average values for comparable stocks, (14.111). Projected Growth (PEG Ratio) (0.075) is also within normal values, averaging (0.686). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (1.017) is also within normal values, averaging (0.827).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. XELB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XELB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
NCI | XELB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 97 | 97 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 44 Fair valued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 98 | |
PRICE GROWTH RATING 1..100 | 99 | 97 | |
P/E GROWTH RATING 1..100 | 96 | 7 | |
SEASONALITY SCORE 1..100 | 39 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XELB's Valuation (40) in the Information Technology Services industry is in the same range as NCI (44) in the Miscellaneous Commercial Services industry. This means that XELB’s stock grew similarly to NCI’s over the last 12 months.
XELB's Profit vs Risk Rating (100) in the Information Technology Services industry is in the same range as NCI (100) in the Miscellaneous Commercial Services industry. This means that XELB’s stock grew similarly to NCI’s over the last 12 months.
NCI's SMR Rating (89) in the Miscellaneous Commercial Services industry is in the same range as XELB (98) in the Information Technology Services industry. This means that NCI’s stock grew similarly to XELB’s over the last 12 months.
XELB's Price Growth Rating (97) in the Information Technology Services industry is in the same range as NCI (99) in the Miscellaneous Commercial Services industry. This means that XELB’s stock grew similarly to NCI’s over the last 12 months.
XELB's P/E Growth Rating (7) in the Information Technology Services industry is significantly better than the same rating for NCI (96) in the Miscellaneous Commercial Services industry. This means that XELB’s stock grew significantly faster than NCI’s over the last 12 months.
| NCI | XELB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| Stochastic ODDS (%) | 1 day ago 89% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 89% | 2 days ago 89% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 89% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 90% | 7 days ago 82% |
| Declines ODDS (%) | 7 days ago 90% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NCI’s FA Score shows that 0 FA rating(s) are green while XELB’s FA Score has 1 green FA rating(s).
- NCI’s FA Score: 0 green, 5 red.
- XELB’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NCI’s TA Score shows that 5 TA indicator(s) are bullish while XELB’s TA Score has 4 bullish TA indicator(s).
- NCI’s TA Score: 5 bullish, 5 bearish.
- XELB’s TA Score: 4 bullish, 4 bearish.
Price Growth
NCI (@Apparel/Footwear) experienced а +0.78% price change this week, while XELB (@Apparel/Footwear) price change was +17.13% for the same time period.
The average weekly price growth across all stocks in the @Apparel/Footwear industry was +0.83%. For the same industry, the average monthly price growth was -0.89%, and the average quarterly price growth was -3.66%.
Reported Earning Dates
XELB is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Apparel/Footwear (+0.83% weekly)Apparel/footwear might be slightly more ‘cyclical’ in the largely non-cyclical category of non-durables. While digital giants like Amazon have been rapidly expanding their presence, traditional clothing/footwear retailers have also been bulking up their online presence in recent years, to milk the burgeoning trend of online shopping among consumers across the globe. The apparel and footwear retail market was valued at around $ 360 billion in 2018, and this figure was expected to reach about $386 billion by 2020 (according to a Statista report). NIKE, Inc, V.F. Corporation and Under Armour, Inc. are some of the companies with the largest U.S. stock market caps in this segment.
Advertisement
NCI and
Correlation & Price change
A.I.dvisor tells us that NCI and JXG have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NCI and JXG's prices will move in lockstep.
| Ticker / NAME | Correlation To NCI | 1D Price Change % | ||
|---|---|---|---|---|
| NCI | 100% | +3.65% | ||
| JXG - NCI | 20% Poorly correlated | -0.21% | ||
| XELB - NCI | 13% Poorly correlated | -5.58% | ||
| VNCE - NCI | 6% Poorly correlated | +3.49% | ||
| LITB - NCI | 6% Poorly correlated | +1.96% | ||
| PLCE - NCI | 4% Poorly correlated | N/A | ||
More | ||||
XELB and
Correlation & Price change
A.I.dvisor tells us that XELB and RL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XELB and RL's prices will move in lockstep.
| Ticker / NAME | Correlation To XELB | 1D Price Change % | ||
|---|---|---|---|---|
| XELB | 100% | -5.58% | ||
| RL - XELB | 22% Poorly correlated | +0.34% | ||
| VFC - XELB | 22% Poorly correlated | +1.92% | ||
| JL - XELB | 21% Poorly correlated | -2.29% | ||
| VRA - XELB | 21% Poorly correlated | +0.82% | ||
| CROX - XELB | 21% Poorly correlated | +2.11% | ||
More | ||||